Pages
-
Geekwire: University of Washington Initiative Awarded $9.3M to Fight Deadly Malaria Strains in India
By Clare McGrane ...
-
Basia Otto
Human Resources Specialist ...
-
UW Honors I-TECH Director for Contributions to Lifelong Learning
Associate Professor Ann Downer, a pioneer of distance learning at the University of Washington, has been named winner of the UW's 2015 Distinguished Contributions to Lifelong Learning Award. Ann Downer, a pioneer of distance learning at the...
-
NPR Goats and Soda: Liver Cancer Is Becoming A Top Killer In Poor Countries
By Susan Brink ...
-
Anya Lewin
Program Operations Specialist, Global WACh ...
-
Jared Baeten, MD, PhD Awarded 2013 ASPPH/Pfizer Young Investigator's Research Award
Congratulations to Associate Professor Jared Baeten, MD, PhD, who was awarded Association of Schools and Programs of Public Health / Pfizer Young Investigator Research Award. ...
-
Earth is ‘really quite sick now’ and in danger zone in nearly all ecological ways, study says
Earth has pushed into “the danger zone,” not just for an overheating planet that’s losing its natural areas, but for the well-being of people living on it, according to a new study. ...
-
An Assessment of HIV Drug Resistance among Seroconversions in Users of Pre-Exposure Prophylaxis in Kenya
To assess the frequency of HIV-1 drug resistance mutations among PrEP clients who test HIV positive after initiating any PrEP products. Further, the study will explore the relationship between HIV drug resistance and PrEP adherence in individuals who...
-
From Gaza to Syria to Ukraine, attacks on health care are part of warfare
The year 2022 set a grim record — 1,989 attacks on health-care facilities and their personnel, the worst total number in the decade since the Safeguarding Health in Conflict Coalition began its sobering count. This year is on track to be even more...
-
Impower-022 Phase III safety and efficacy trial of once monthly Islatravir for HIV prevention among cisgender women
This is a large randomized, active-controlled clinical trial to determine safety and efficacy of a novel antiretroviral agent to prevent HIV infection in cisgender women. The trial is sponsored by Merck with leadership from Merck, ICRC and the Bill and...